Back
Intellia Therapeutics Stock Price Chart
"This Changes Everything" - Trump Hands Millions Massive IRS Gift
Learn More Here
Sell
18
NTLA
Intellia Therapeutics
Last Price:
13.49
Seasonality Move:
5.23%
7 Day Trial
ALL ACCESS PASS
$
7
Trump's IRS Hands Massive 'Victory Gift' To 401K Owners
Shield your IRA, 401(k) and pension savings from this coming anti-Trump backlash.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NTLA is experiencing selling pressure, which indicates risk of future bearish movement.
Intellia Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 15.1 | Sell |
| 20-day SMA: | 15.33 | Sell |
| 50-day SMA: | 18.25 | Sell |
| 200-day SMA: | 23.2 | Sell |
| 8-day EMA: | 14.6 | Sell |
| 20-day EMA: | 15.73 | Sell |
| 50-day EMA: | 17.78 | Sell |
| 200-day EMA: | 23.04 | Sell |
Intellia Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.18 | Sell |
| Relative Strength Index (14 RSI): | 30.94 | Sell |
| Chaikin Money Flow: | -2607453 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (14.04 - 18.76) | Sell |
| Bollinger Bands (100): | (17.31 - 24.45) | Sell |
Intellia Therapeutics Technical Analysis
| Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Intellia Therapeutics Stock
Is Intellia Therapeutics Stock a Buy?
- Intellia Therapeutics share price is 13.12 while NTLA 8-day simple moving average is 15.10, which is a Sell signal.
- The stock price of NTLA is 13.12 while Intellia Therapeutics 20-day SMA is 15.33, which makes it a Sell.
- Intellia Therapeutics 50-day simple moving average is 18.25 while NTLA share price is 13.12, making it a Sell technically.
- NTLA stock price is 13.12 and Intellia Therapeutics 200-day simple moving average is 23.20, creating a Sell signal.
NTLA Technical Analysis vs Fundamental Analysis
Sell
18
Intellia Therapeutics (NTLA)
is a Sell
Is Intellia Therapeutics a Buy or a Sell?
-
Intellia Therapeutics stock is rated a Sell
The current Intellia Therapeutics [NTLA] share price is $13.12. The Score for NTLA is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.
Intellia Therapeutics Stock Info
Market Cap:
1.34B
Price in USD:
13.12
Share Volume:
4.45M
Intellia Therapeutics 52-Week Range
52-Week High:
34.87
52-Week Low:
13.54
Sell
18
Intellia Therapeutics (NTLA)
is a Sell
Intellia Therapeutics Share Price Forecast
-
What is the Intellia Therapeutics stock price today?
The Intellia Therapeutics stock price is 13.12 USD today. -
Will NTLA stock go up or go down?
Intellia Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Intellia Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Intellia Therapeutics is overvalued.
Is Intellia Therapeutics Stock a Buy?
- Intellia Therapeutics share price is 13.12 while NTLA 8-day exponential moving average is 14.60, which is a Sell signal.
- The stock price of NTLA is 13.12 while Intellia Therapeutics 20-day EMA is 15.73, which makes it a Sell.
- Intellia Therapeutics 50-day exponential moving average is 17.78 while NTLA share price is 13.12, making it a Sell technically.
- NTLA stock price is 13.12 and Intellia Therapeutics 200-day simple moving average is 23.04, creating a Sell signal.
Fundamental Analysis of Intellia Therapeutics
Is Intellia Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.08 per share, and a decrease next year of $0.19 per share.
Technical Analysis of Intellia Therapeutics
Should I short Intellia Therapeutics stock?
- NTLA Moving Average Covergence Divergence (MACD) indicator is -1.18, suggesting Intellia Therapeutics is a Sell
- Intellia Therapeutics Relative Strength Index (RSI) is 30.94, which suggest Intellia Therapeutics is oversold
- The Bollinger Bands (25) for Intellia Therapeutics is (14.04 - 18.76), which suggest Intellia Therapeutics is a Sell
- The Bollinger Bands (100) for Intellia Therapeutics is (17.31 - 24.45), which suggest Intellia Therapeutics is a Sell
* Intellia Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.